Pharmanutra S.p.A. (BIT: PHN)

Market Cap	524.59M
Revenue (ttm)	113.13M
Net Income (ttm)	16.27M
Shares Out	9.61M
EPS (ttm)	1.69
PE Ratio	32.39
Forward PE	26.45
Dividend	0.85 (1.58%)
Ex-Dividend Date	n/a

Volume	3,689
Open	52.10
Previous Close	53.20
Day's Range	51.50 - 54.00
52-Week Range	44.85 - 63.50
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company’s products primarily include SiderAL, SiderAL Forte, SiderAL...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 105
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2023, Pharmanutra's revenue was 101.03 million, an increase of 21.64% compared to the previous year's 83.06 million. Earnings were 12.83 million, a decrease of -14.73%.